Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

AUREOMYCIN 110 G DIN 02242817

Status: Cancelled Post Market
Holder: ZOETIS CANADA INC
Molecule: CHLORTETRACYCLINE HYDROCHLORIDE (CHLORTETRACYCLINE CALCIUM)

Health Canada record

Active ingredient(s)CHLORTETRACYCLINE HYDROCHLORIDE (CHLORTETRACYCLINE CALCIUM) 110 G
Dosage formDrug Premix
RouteOral
SchedulePRESCRIPTION
ClassVeterinary
ATC
Original market date17-Sep-2001
Current status date06-Jul-2015
SourceHealth Canada DPD

Establishment licence of the holder

Zoetis Canada Inc — licence 102076, currently licensed, last inspection rating C (2023-10-05).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing CHLORTETRACYCLINE HYDROCHLORIDE (CHLORTETRACYCLINE CALCIUM)

DINProductCompanyFormStrengthStatus
02230724AUREOMYCIN 100G PREMIXHOFFMANN-LA ROCHE LIMITEDDrug PremixCHLORTETRACYCLINE HYDROCHLORIDE (CHLORTETRACYCLINE CALCIUM) 220 GCancelled Post Market
02230723AUREOMYCIN 50G PREMIXHOFFMANN-LA ROCHE LIMITEDDrug PremixCHLORTETRACYCLINE HYDROCHLORIDE (CHLORTETRACYCLINE CALCIUM) 110 GCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
153652014-03-04New Drug Submission (NDS)TRANSFER OF DRUG IDENTIFICATION NUMBER (DIN)
86922007-04-05Supplement to a New Drug Submission (SNDS)ALTERNATE SOURCE OF ACTIVE INGREDIENT
84382006-12-01Supplement to a New Drug Submission (SNDS)ADDITIONAL CLAIM FOR SWINE
62782000-09-12New Drug Submission (NDS)
Request a quote for AUREOMYCIN 110 G

How to read a Canadian DIN record